I am joined today by Shane Pennington. He is an appellate lawyer who focuses on regulatory litigation for clients in a diverse array of industries. He has clerked for federal judges on the D.C. Circuit, the Fifth Circuit, and the U.S. District Court for the District of Columbia, and he brings specialized knowledge to our conversations. Today we discuss why there isn't more research on cannabis and how the model the US uses favors big pharma.